Skip to main content
Etropal AD logo

Etropal AD — Investor Relations & Filings

Ticker · ETR ISIN · BG1100001038 LEI · 747800F04CMOK74FIJ68 BSOBGN Manufacturing
Filings indexed 84 across all filing types
Latest filing 2025-07-29 Audit Report / Informat…
Country BG Bulgaria
Listing BSOBGN ETR

About Etropal AD

https://www.etropal.eu/

Etropal AD is a manufacturer of disposable medical devices, primarily focused on providing life-sustaining care for patients with end-stage renal disease. The company's core activities include the research, development, and production of a comprehensive range of hemodialysis consumables, such as capillary dialyzers. In addition to its focus on dialysis solutions, the company is also active in the field of orthopedics and traumatology. This secondary business line involves the manufacturing of endoprostheses, implants, specialized bioceramic materials, and surgical instruments. With over thirty years of experience, Etropal AD offers a broad spectrum of products that meet high standards of safety and quality.

Recent filings

Filing Released Lang Actions
658443-provereni BEL.ETROPAL_Ind. _GFO_2025_01.01.2025_30.06.2025po MSS.pdf
Audit Report / Information Classification · 95% confidence The document is a detailed set of explanatory notes to the annual non-consolidated financial statements of 'ETROPAL' AD. It covers accounting policies, management structure, and compliance with International Financial Reporting Standards (IFRS). Although the header mentions a period of 01.01.2025 - 30.06.2025, the document explicitly states it is an integral part of the annual financial report ending on December 31, 2025, and discusses annual accounting policies. Given the comprehensive nature of the financial disclosures and the fact that it is a full report rather than a summary or announcement, it is classified as an Annual Report (10-K equivalent for this jurisdiction). H1 2025
2025-07-29 Bulgarian
658442-ETROPAL_Ind. GFO 2025_01.01.2025_30.06.2025_po MSS.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for 'Etropal' AD, covering the period ending June 30, 2025. It includes an Income Statement, Statement of Financial Position, Cash Flow Statement, and Statement of Changes in Equity. Since it provides substantive financial data for a period shorter than a full fiscal year (interim period), it is classified as an Interim/Quarterly Report. H1 2025
2025-07-29 Bulgarian
658447-Etropal_Q2_2025_Additional_information.pdf
Management Reports Classification · 95% confidence The document is titled 'Additional Information to the Interim Financial Report' for the period ending 30.06.2025. It provides management commentary, shareholder data, and disclosures required by Bulgarian regulatory ordinance regarding interim financial reporting. While it references an interim report, it functions as the management discussion and analysis (MDA) component of the interim reporting package, detailing business trends, organizational changes, and legal/financial disclosures. Therefore, it is classified as a Management Report (MDA). H1 2025
2025-07-29 Bulgarian
658446-Etropal_Q2_2025_Internal_information.pdf
Regulatory Filings Classification · 95% confidence The document is a short notification (under 750 characters) from 'Etropal AD' regarding the disclosure of 'inside information' pursuant to Article 7 of the EU Market Abuse Regulation (MAR). It directs the reader to an external financial media link (x3news.com) to view the actual information. Since it is a brief announcement of a disclosure rather than the full report itself, it falls under the category of a general regulatory announcement.
2025-07-29 Bulgarian
Declaration_100о_Q1'2025_ETR.pdf
Earnings Release Classification · 99% confidence The document is titled "ДЕКЛАРАЦИЯ" (Declaration) and explicitly states that the signatories declare the accuracy of the "Междинният финансов отчет за първо тримесечие на 2025 г." (Interim financial report for the first quarter of 2025) and the "Междинният доклад за дейността" (Interim activity report). The mention of an 'Interim financial report' for a specific short period (first quarter) strongly indicates this is related to a periodic, non-annual financial disclosure. This aligns best with the definition of an Interim / Quarterly Report (IR). Although this specific document is a declaration *about* the report, in many regulatory contexts, the declaration itself is filed alongside or as part of the comprehensive quarterly filing package. Given the content focuses entirely on the Q1 interim results, IR is the most appropriate classification over a general Regulatory Filing (RNS). The document length is short (1383 chars), but it is the core declaration required for the interim report, not just an announcement that the report is available. Q1 2025
2025-04-28 Bulgarian
646666-Etropal_Q1_2025_Prilojenie_4.pdf
Regulatory Filings Classification · 95% confidence The document is written in Bulgarian and references 'НАРЕДБА № 2 от 9.11.2021 г. за първоначално и последващо разкриване на информация при публично предлагане на ценни книжа и допускане на ценни книжа до търговия на регулиран пазар' (Regulation No. 2 of 09.11.2021 on initial and subsequent disclosure of information for public offering of securities and admission of securities to trading on a regulated market). It systematically addresses various mandatory disclosure points (change in control, insolvency, material transactions, auditor changes, litigation, shareholdings, etc.). This structure strongly suggests a mandatory periodic or event-driven regulatory disclosure filing required by a national financial regulator, rather than a specific report like an Annual Report (10-K) or an Earnings Release (ER). Since it covers mandatory disclosures that don't fit perfectly into the specific categories like DIRS, DIV, or DEF 14A, and it is a formal regulatory filing structure, the most appropriate general category for miscellaneous, mandatory regulatory disclosures that don't fit elsewhere is 'Regulatory Filings' (RNS). The document is short and appears to be a summary of required disclosures, not the full underlying report itself.
2025-04-28 Bulgarian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.